Massivemarkets

NAGE

Niagen Bioscience, Inc. Common Stock

Nasdaq · usd

$2.04+0.03 (+1.49%)
As of 6:54:53 PM EST on Nov 17, 2026 · 15-minute delayed

Niagen Bioscience, Inc. Common Stock (NAGE) trades at $2.04 (+1.49%) as of 6:54:53 PM EST on Nov 17, 2026, -18.40% over the past month. Market cap is $159.19M, with 8.9 days to cover in short interest.

Stock performance

How Niagen Bioscience, Inc. Common Stock (NAGE) stock has performed from one day to one year, with its 52-week range.

+1.49%
+$0.03 over 1D
$1.96$1.99$2.01$2.044:40 AM11:00 AM12:40 PM2:25 PM8:00 PM$2.04
1D
+1.49%
1W
-5.12%
1M
-18.40%
YTD
-67.92%
1Y
-70.26%
52-wk range
$1.95 – $7.12

Key statistics

Today's trading snapshot for NAGE: day range, open, previous close, volume and market cap.

Day range
$1.95 – $2.05
Open
$2.00
Prev close
$2.01
Volume
1.03M
Market cap
$159.19M
Shares out
79.2M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Niagen Bioscience, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
15.55
P/S
1.30
P/B
1.92
P/FCF
34.76
ROE
12.3%
ROA
9.4%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 16, 2026

8-K filings

Material corporate events Niagen Bioscience, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On November 4, 2026, Niagen Bioscience, Inc. (the "Company") issued a press release announcing its earnings for the quarter ended September 30, 2026.

  • Investor presentationAug 4, 2026

    On August 4, 2026, the Company released a corporate presentation which it made available on its website.

  • Annual meeting resultsJun 29, 2026

    Set forth below are the results of the matters submitted for a vote of stockholders at the Company's 2026 Annual Meeting. Proposal 1 — Election of directors. The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders...

  • Investor presentationMay 6, 2026

    On May 6, 2026, the Company released a corporate presentation which it made available on its website.

  • the Board of Directors (the "Board") of Niagen Bioscience, Inc. (the "Company") approved an increase in the authorization under the Company's share repurchase program. Under the amended authorization, the Company may repurchase up to $20.0 million of its outstanding common stock, representing an increase from the previously authorized $10.0 million share repurchase program approved by the Board on October 31, 2025.

Dividend history and stock splits

Niagen Bioscience, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 3.1887751-for-1Dec 7, 2006

NAGE short interest

How heavily NAGE is shorted: shares short, days to cover and average daily volume.

Days to cover
8.9
Short interest
4.35M
Avg volume
487.93K

As of · reported to FINRA twice monthly.

NAGE news

The latest news and headlines about Niagen Bioscience, Inc. Common Stock (NAGE).

Frequently asked questions

What is the Niagen Bioscience, Inc. Common Stock (NAGE) stock price today?

Niagen Bioscience, Inc. Common Stock (NAGE) is trading at $2.04 (+1.49% on the day) as of 6:54:53 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Niagen Bioscience, Inc. Common Stock?

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions.

What is the short interest in NAGE?

As of Oct 30, 2026, NAGE has 4.35M shares short and 8.9 days to cover.

What exchange is NAGE listed on?

Niagen Bioscience, Inc. Common Stock (NAGE) trades on Nasdaq in USD, in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry.

Build with AI

Build an analysis of NAGE with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a NAGE analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.